Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000340613

Medchemexpress LLC DMHCA | 79066-03-8 | 99.9% | 50 MG
SDP

Catalog No. 5000340613
Encompass_Preferred

DMHCA is a potent and selective LXR agonist that specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. It also exhibits anti-inflammatory effects and is suitable for research on cholesterol homeostasis and diabetes.

  • Potent and selective LXR agonist.
  • Activates cholesterol efflux pathway.
  • Exhibits anti-inflammatory effects.
  • Suitable for research on cholesterol homeostasis.
  • Suitable for research on diabetes.
  • Restores membrane fluidity in diabetic cells ex vivo.
  • Enhances erythrocyte progenitor production.
  • Restores cholesterol homeostasis in diabetic retina in vivo.

Catalog No. 50-003-40613 Supplier Medchemexpress LLC Supplier No. HY12909850MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DMHCA is a potent and selective LXR agonist that specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. It also exhibits anti-inflammatory effects and is suitable for research on cholesterol homeostasis and diabetes.

  • Potent and selective LXR agonist.
  • Activates cholesterol efflux pathway.
  • Exhibits anti-inflammatory effects.
  • Suitable for research on cholesterol homeostasis.
  • Suitable for research on diabetes.
  • Restores membrane fluidity in diabetic cells ex vivo.
  • Enhances erythrocyte progenitor production.
  • Restores cholesterol homeostasis in diabetic retina in vivo.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.